Ascletis Pharma Inc. is an innovative R&D driven biotech company listed on the Hong Kong Stock Exchange. The company is committed to developing and commercializing innovative drugs in the areas of viral diseases, metabolic diseases, and cancer. Ascletis covers the entire value chain from discovery and development to commercialization.
Focus Areas
Notable Investments
